On June 4th, 2024 we're bringing you valuable information from speakers from Hyatt Life Sciences and Genzada Pharmaceuticals regarding plant-based treatments for cancer and other diseases. This event could change your life!
You can attend in person in Hutchinson, KS, at HCC Stringer Fine Arts Center (Gallery Theatre) or watch an online live stream on our Facebook page or X (Twitter) page! If you plan to attend in person, the HCC Stringer Fine Arts Center is located off E 11th Ave, between Gowans Stadium and Hutchinson Sports Arena. The event will begin at 5:30 pm CT on June 4th. Gene Zaid, PhD; Jason West, JD; Jack Mull, MD; and people just like you who have used these plant-based treatments themselves will be sharing about a new, natural drug that is showing promising results in treating cancer and other diseases.
-
Headquartered in America’s heartland, Sterling, Kansas, Hyatt Life Sciences continually searches for unique botanical entities and combinations that have been used traditionally in their countries of origin for hundreds of years. Rather than depending only on tradition and legend as many nutraceutical companies do, scientists at Hyatt Life Sciences research, test, and evaluate each herb, root, and component to discover the scientific reason for the ingredient’s benefit. We offer products only after each ingredient has been thoroughly researched for benefit, safety, and purity. At Hyatt, we are committed to Putting Science Behind the Tradition.
-
Nature has always been a powerful ally against disease. Today, Genzada Pharmaceuticals is harnessing its potential in a rigorous drug development process. After identifying promising natural compounds found in plants, we synthesize them to create unique pharmaceutical formulations that target cancer in new ways. While many cancer-fighting drugs are derived from plants, Genzada is focused on natural compounds that pair efficacy with less toxicity. Their motto is Little Pharma, Big Science.
-
Founder and Chief Executive Officer of Genzada Pharmaceuticals. Born and raised in a refugee camp on the outskirts of Jerusalem, Gene Zaid was determined to make his way to the United States to pursue an education. Seeing the suffering and rudimentary medical care in the camp, he was drawn to medicine and had a keen interest in the traditional, age-old remedies to treat a host of ailments—even cancer. His long-held dream of coming to U.S. to pursue an education came true, and he wasted no time pursuing two of his passions, chemistry and math—earning a bachelor’s degree in both from Kansas Wesleyan, followed by a master’s degree and PhD in chemistry from Wichita State University. In 1983, Zaid founded JACAM Chemicals. Like many other disruptors (Apple, Amazon, Hewlett-Packard, Disney, and Dell), his start-up venture began in his garage and quickly grew into one of the most respected companies in the oil and gas industry. Over the next 20 years, he earned more than 50 patents for his unique inventions. Despite his success, Zaid never lost his passion for medicine and its ability to ease human suffering. Remembering the medicinal plants of his youth—plants that have been used for centuries throughout the Middle East—he began to investigate them. Extracting components from plants known for their healing properties such a black calla lily, he synthesized them and combined them in a unique formulation that has shown efficacy against many types of cancer in preclinical studies. After selling his oil and gas company, Zaid formed Genzada Pharmaceuticals in 2010. Today, he devotes his time, knowledge and resources to eliminating cancer and other serious diseases. He currently holds eight patents for his novel pharmaceutical applications, and under his leadership, the company’s first anti-cancer agent, GZ17-6.02, is now undergoing Phase I clinical trials.
-
Executive Vice President of Genzada Pharmaceuticals. Shepherding scientific discoveries through a complex gauntlet of research, validation, funding, patent protection, government approvals, and manufacturing is nothing new for Jason West. Before he co-founded Genzada Pharmaceuticals, West served as the vice president and general counsel of Jacam Chemical Company after completing his law degree in 2002. It was a natural fit after watching his chemist and entrepreneur father—Jacam founder Gene Zaid—disrupt the oil and gas industry with his novel inventions. In 2009, West assumed the mantle of president and guided the company through dramatic 430 percent revenue growth. Later, he was instrumental in the $300-million acquisition of Jacam by Calgary-based CES Energy Solutions. In 2010, West and Zaid started Genzada Pharmaceuticals to investigate promising plant-based therapeutics that target difficult-to-treat cancers. As Genzada’s executive vice president, West is instrumental in the development and commercialization of novel oncology-focused therapies the company hopes will ease human suffering, including the development of the company’s first novel agent—GZ17-6.02. Since 2015, West has helped raise over $45 million in equity capital to support Genzada’s efforts. In addition to his role at Genzada, West serves as the chief executive officer of Hyatt Life Sciences, a nutraceutical manufacturing and sales company with proprietary formulations intended for health, wellness and dietary support. He is also currently chairman of the board of GeoChemicals, LLC. West holds a bachelor’s degree in biology from Sterling College. He earned his juris doctor degree from Vermont Law School.
The information provided at this event is for general informational purposes only and the information is not intended to be and does not constitute legal or medical advice. Anyone relying upon this information is advised to use their own judgment including consultation with their own physician, attorney, or other professionals before taking action based upon any information presented at this event.